CIK 0000948320 · Accelerated filer
LifeMD, Inc.
Sign in to watch- Ticker
- LFMD
- Exchange
- Nasdaq
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 760238453
- Phone
- (866) 351-5907
- Business address
- 236 FIFTH AVENUE, SUITE 400, NEW YORK, NY, 10001
- Former names
- CONVERSION LABS, INC., Immudyne, Inc.
Securities
- LFMD Common Stock Nasdaq
- LFMDP 8.875% Series A Cumulative Perpetual Preferred Stock Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 86 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-23 | Galluppi Stefan Chief Innovation Officer | Purchase | +4,608 | $2.17 | $10K | 12,449 |
| 2023-05-23 | Schreiber Justin CEO | Purchase | +32,336 | $2.06 | $67K | 2,844,620 |
| 2023-05-23 | Galluppi Stefan Chief Innovation Officer | Purchase | +10,000 | $2.17 | $22K | 17,841 |
| 2023-05-22 | Schreiber Justin CEO | Purchase | +17,664 | $2.15 | $38K | 2,812,284 |
| 2023-02-09 | LAROVERE JOAN Director | Grant or award | +75,000 | 75,000 | ||
| 2023-02-09 | LAROVERE JOAN Director | Grant or award · Stock Option (Right to Buy) | +37,500 | 37,500 | ||
| 2023-01-27 | Benathen Marc David Chief Financial Officer | Option exercise | +25,000 | 77,554 | ||
| 2023-01-27 | Benathen Marc David Chief Financial Officer | Option exercise · Restricted Stock | −25,000 | 25,000 | ||
| 2023-01-03 | FRIEDEMAN JESSICA Chief Marketing Officer | Grant or award | +150,000 | 150,000 | ||
| 2022-12-15 | Walsh Kathleen E Director | Grant or award | +75,000 | 75,000 | ||
| 2022-12-15 | Walsh Kathleen E Director | Grant or award · Stock Option (Right to Buy) | +37,500 | 37,500 | ||
| 2022-11-22 | Velge Bertrand Director | Grant or award | +10,000 | 926,666 | ||
| 2022-11-22 | Strawn John R Jr Director | Grant or award | +10,000 | 283,347 | ||
| 2022-09-14 | Jindal Piyush Director | Grant or award | +75,000 | 75,000 | ||
| 2022-09-14 | Jindal Piyush Director | Grant or award · Stock Option (Right to Buy) | +37,500 | 37,500 | ||
| 2022-05-18 | BHATIA NAVEEN Director | Purchase | +50,000 | $2.14 | $107K | 246,349 |
| 2022-04-04 | Wijnker Dennis Chief Technology Officer | Grant or award | +20,000 | 20,000 | ||
| 2022-03-14 | Yecies Eric Harold General Counsel & CCO | Purchase | +5,000 | $3.14 | $16K | 51,000 |
| 2022-03-10 | DiTrolio Joseph Director | Purchase | +2,000 | $3.28 | $7K | 24,500 |
| 2022-02-11 | Alvarez Nicholas P Chief Acquisition Officer | Gift | +60,000 | 169,288 |
Page 7 of 8 · 146 trades